These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23615477)

  • 21. Combining proteomics, serum biomarkers and bioinformatics to discriminate between esophageal squamous cell carcinoma and pre-cancerous lesion.
    Zhai XH; Yu JK; Lin C; Wang LD; Zheng S
    J Zhejiang Univ Sci B; 2012 Dec; 13(12):964-71. PubMed ID: 23225851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of chemical elements in esophageal squamous cell carcinoma in Anyang, China: a case-control study based on machine learning methods.
    Lin T; Liu T; Lin Y; Zhang C; Yan L; Chen Z; He Z; Wang J
    BMJ Open; 2017 Sep; 7(9):e015443. PubMed ID: 28947442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of plasma miRNA-718 for esophageal squamous cell carcinoma.
    Sun L; Dong S; Dong C; Sun K; Meng W; Lv P; Yin H; Ming L; He F
    Cancer Biomark; 2016; 16(2):265-73. PubMed ID: 26756617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma.
    Chen Z; Gao Y; Huang X; Yao Y; Chen K; Zeng S; Mao W
    J Pharm Biomed Anal; 2021 Apr; 197():113937. PubMed ID: 33609949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum peptidome patterns for early screening of esophageal squamous cell carcinoma.
    Fan NJ; Gao CF; Zhao G; Wang XL; Qiao L
    Biotechnol Appl Biochem; 2012; 59(4):276-82. PubMed ID: 23586861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.
    Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L
    Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma.
    Zhang C; Wang C; Chen X; Yang C; Li K; Wang J; Dai J; Hu Z; Zhou X; Chen L; Zhang Y; Li Y; Qiu H; Xing J; Liang Z; Ren B; Yang C; Zen K; Zhang CY
    Clin Chem; 2010 Dec; 56(12):1871-9. PubMed ID: 20943850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
    Sun J; Song K; Feng X; Gao S
    Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
    Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
    Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis.
    Bai Y; Lin H; Fang Z; Luo Q; Fang Y; Su Y; Hu Q; Duan H; Chen F; Zhang ZY
    Biomark Med; 2017 May; 11(5):431-441. PubMed ID: 28621611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Wang W; He X; Zheng Z; Ma X; Hu X; Wu D; Wang M
    Mol Cancer; 2017 Apr; 16(1):75. PubMed ID: 28376832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma.
    Zhu Q; Huang L; Yang Q; Ao Z; Yang R; Krzesniak J; Lou D; Hu L; Dai X; Guo F; Liu F
    Nanoscale; 2021 Oct; 13(39):16457-16464. PubMed ID: 34648610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a metabolic pathway-based pseudo-targeted metabolomics method using liquid chromatography coupled with mass spectrometry.
    Xu J; Li J; Zhang R; He J; Chen Y; Bi N; Song Y; Wang L; Zhan Q; Abliz Z
    Talanta; 2019 Jan; 192():160-168. PubMed ID: 30348373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma.
    Xu SY; Liu Z; Ma WJ; Sheyhidin I; Zheng ST; Lu XM
    Biomarkers; 2009 Aug; 14(5):340-6. PubMed ID: 19552569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum miR-1297: a promising diagnostic biomarker in esophageal squamous cell carcinoma.
    Wang C; Li Q; Liu F; Chen X; Nesa EU; Guan S; Liu B; Han L; Tan B; Wang D; Chen P; Liu X; Zhang H; Sun Y; Cheng Y
    Biomarkers; 2016 Sep; 21(6):517-22. PubMed ID: 27152453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum vascular endothelial growth factor receptor-3 levels in patients with esophageal squamous cell cancer.
    Su Mer A; Demir A; Kemik AS; Yavuz A; Suvak B; Du Lger AC; Purisa S; Kemik O
    Ann Ital Chir; 2017; 88():20-25. PubMed ID: 28447586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma.
    Dong S; Yin H; Dong C; Sun K; Lv P; Meng W; Ming L; He F
    Dis Markers; 2016; 2016():1857067. PubMed ID: 26989293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
    Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma.
    Liao Y; Xing S; Xu B; Liu W; Zhang G
    Oncotarget; 2017 May; 8(18):30050-30062. PubMed ID: 28415791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolomics of Esophageal Squamous Cell Carcinoma Tissues: Potential Biomarkers for Diagnosis and Promising Targets for Therapy.
    Xu J; Cao W; Shao A; Yang M; Andoh V; Ge Q; Pan HW; Chen KP
    Biomed Res Int; 2022; 2022():7819235. PubMed ID: 35782075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.